// App-Quantinova.ai

e23096 : Benefits and limitations of liquid biopsy in one patients clinical trial paradigm.

Researchers

Presenter

  • Jean-Francois Laes

Principal Investigators

  • N/A

Medical Centers

  • OncoDNA, Gosselies, Belgium

Locations

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Extracellular signal-regulated kinase

  • Serine/threonine-protein kinase mTOR

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final